It wasn't so long ago that Intuitive Surgical (Nasdaq: ISRG ) was one of the cleanest growth stories in med-tech, as hospitals seemin...
It wasn't so long ago that Intuitive Surgical (Nasdaq: ISRG ) was one of the cleanest growth stories in med-tech, as hospitals seemin...
The already-successful new prostate cancer drug Zytiga is not solely responsible for turning around the fortunes of Johnson & Johnson ...
In what has become a red-hot stock market for med-tech stocks, it's the rare quality company that hasn't taken part in the rally. ...
Biotech investors are a stubborn and hopeful lot, and many of them will never give up the ship. While confidence and patience are admirable...